NCT03939962 2022-01-26
Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma
Henan Cancer Hospital
Phase 2 Unknown
Henan Cancer Hospital
Fujian Cancer Hospital
International Group of Endovascular Oncology
Shenzhen Hornetcorn Bio-technology Company, LTD
Binex